research chemical raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-09-11. Anything still debated is marked as such rather than presented as settled.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water. |
| Typical storage | -20 °C, desiccated, dark | Protect from repeated temperature changes. |
| Common analytical method | LC-MS or HPLC-UV | Reference standard required for comparison. |
| Common synonyms | SR9009; Stenabolic; REV-ERB agonist | Vendor naming may vary. |
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
In Belizean folklore, there are the legends of Lang Bobi Suzi, La Llorona, La Sucia, Tata Duende, Anansi, Xtabay, Sisimite and the cadejo. Most of the public holidays in Belize are traditional Commonwealth and Christian holidays, although some are specific to Belizean culture such as Garifuna Settlement Day and Heroes and Benefactors' Day, formerly Baron Bliss Day. In addition, the month of September is considered a special time of national celebration called September Celebrations with a whole month of activities on a special events calendar. Besides Independence Day and St. George's Caye Day, Belizeans also celebrate Carnival during September, which typically includes several events spread across multiple days, with the main event being the Carnival Road March, usually held the Saturday before 10 September. In some areas of Belize, it is celebrated at the traditional time before Lent (in February).
Spondylosis, or degenerative arthritis of the spine, occurs when the intervertebral disc undergoes degenerative changes, causing the disc to fail at cushioning the vertebrae. There is an association between intervertebral disc space narrowing and lumbar spine pain. The space between the vertebrae becomes more narrow, resulting in compression and irritation of the nerves. Spondylolithesis is the anterior shift of one vertebra compared to the neighboring vertebra. It is associated with age-related degenerative changes as well as trauma and congenital anomalies. Spinal stenosis can occur in cases of severe spondylosis, spondylotheisis and age-associated thickening of the ligamentum flavum. Spinal stenosis involves narrowing of the spinal canal and typically presents in patients greater than 60 years of age. Neurogenic claudication can occur in cases of severe lumbar spinal stenosis and presents with symptoms of pain in the lower back, buttock or leg that is worsened by standing and relieved by sitting. Vertebral compression fractures occur in four percent of patients presenting with lower back pain. Risk factors include age, female gender, history of osteoporosis, and chronic glucocorticoid use. Fractures can occur as a result of trauma but in many cases can be asymptomatic.
=== Colorimetrics === The use of colorimetric test kits for explosive detection is one of the oldest, simplest, and most widely used methods for the detection of explosives. Colorimetric detection of explosives involves applying a chemical reagent to an unknown material or sample and observing a color reaction. Common color reactions are known and indicate to the user if there is an explosive material present and in many cases the group of explosive from which the material is derived. The major groups of explosives are nitroaromatic explosives, nitrate ester and nitramine explosives, improvised explosives not containing nitro groups which includes inorganic nitrate based explosives, chlorate based explosives, and peroxide based explosives.
== See also == Ergine (lysergic acid amide; LSA; lysergamide) Aztec use of entheogens § Ololiuqui and Tlitliltzin Morning glory § Chemistry and ethnobotany List of entheogens List of psychoactive plants
Sources: en.wikipedia.org
The employees were young men: handsome jocks in form-fitting red-and-white striped soccer shirts; when a patron was celebrating a birthday, the entire restaurant crew came around with a cake and sang TGI Fridays' traditional birthday song. Footage of interviews with patrons from this TGI Fridays was featured in Robert Downey Sr.'s film No More Excuses (1968). The first location closed in 1994 and became a British-style pub called "Baker Street". Although Malachy McCourt's nearby Malachy's singles bar preceded TGI Fridays and Stillman credited the media for creating the term, he had unintentionally created one of the first singles bars. It benefited from the near-simultaneous availability of the birth-control pill and Betty Friedan's book The Feminine Mystique:
Froud, Kristina E.; Wardhaugh, Tina; Banks, Duncan; Saffrey, M. Jill; Stewart, Michael G. (2010). "Colostrinin™ Alleviates Amyloid-β Induced Toxicity in Rat Primary Hippocampal Cultures" (PDF). Journal of Alzheimer's Disease. 20 (2): 423–426. doi:10.3233/JAD-2010-1382. PMID 20164569.
=== Role in synchronized fertilization on dairy farms === By using cows that produce offspring within a one to two-week period, synchronized breeding allows dairy farmers to artificially inseminate cows for maximum pregnancy rates with minimal effort. BST is a placental lactogen (PL) hormone and falls under the class of growth hormone, or somatotropin. It is relevant to the practice of artificially expediting placental development in farm mammals, specifically dairy cattle. The mechanism through which the hormones of this somatotropin exert their effects can be observed at the cellular and molecular level in placental tissue. For mammals exposed to the hormone, bovine somatotropin associates with N-glycosylated proteins that are heavily involved in placental gestation. Knowledge of this and how BST works in conjunction with growth hormones allows for agricultural researchers to experiment on the effects of synchronization in farm animals. Synchronization involves treating cattle with a dose of BST before artificially inseminating them, according to a fixed interval schedule. Synchronization and BST treatment may be used to increase first-service pregnancy rates while following this timed artificial insemination protocol. This would therefore allow agricultural researchers to observe the effects of hormones in relation to natural estrous cycles. Dairy cattle experienced increased rates of pregnancy during synchronization when exposed to BST.
=== Pleiotropy-barrier model === The 'pleiotropy-barrier' model suggests that newly evolved genes, including de novo genes and duplication-related genes, could facilitate evolutionary innovation or evolution of specific functions due to their low (or no) pleiotropic effect, when facing new selective force, based on observations from human gene-disease data.
=== Switzerland === Beak trimming in Switzerland is legal but regulated; it is expected that the practice will be prohibited in the near future. Although the use of cages for layer hens was prohibited in 1992, by 2000 still 59% of flocks (61% of hens) was still debeaked.
Sources: en.wikipedia.org
=== Legal status === On 24 February 2022, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Kapruvia, intended for treatment of moderate-to-severe pruritus associated with chronic kidney disease. The applicant for this medicinal product is Vifor Fresenius Medical Care Renal Pharma France. Difelikefalin was approved for medical use in the European Union in April 2022.
== Further reading == Al-Hussainy, Abbas Ali Abbas, "The civilized achievements of the Akkadian king Naram-Sin A Research in his Artistic Remains and The Date Formulas", ISIN Journal 3, 2022 Boissier, Alfred, "Inscription de Naram-Sin", Revue d’Assyriologie et d’archéologie Orientale, vol. 16, no. 3, pp. 157–64, 1919 Foster, B. R., "Naram-Sin in Martu and Magan", ARRIM 8, pp. 25–44, 1990 Glassner, J. J., "Naram-Sîn Poliorcète. Les avatars d'une sentence divinatoire", Revue d’Assyriologie et d’archéologie Orientale, vol. 77, no. 1, pp. 3–10, 1983 Grayson, A. Kirk, and Edmond Sollberger, "L’insurrection générale contre Narām-Suen", RA70, pp. 103–128, 1976 Lafont, Bertrand, "Une plaque en argile portant une inscription de Naram-Sin d'Agadé", The Third Millennium. Studies in Early Mesopotamia and Syria in Honor of Walter Sommerfeld and Manfred Krebernik, hrsg. v. Arkhipov, Ilya, Kogan, Leonid, Koslova, Natalia (Cuneiform Monographs 50), pp. 408–416, 2020 Piotr Michalowski, "New Sources concerning the Reign of Naram-Sin", Journal of Cuneiform Studies, vol. 32, no. 4, pp. 233–246, (Oct., 1980) Nassouhi, Essad, "Un vase en albatre de Naram - Sin", Revue d’Assyriologie et d’archéologie Orientale, vol. 22, no. 2, pp. 91–91, 1925 [12] A. Poebel, "The ‘Schachtelsatz’ Construction of the Naram-Sîn Text RA XVI 157f.", Miscellaneous Studies, AS 14; Chicago, pp.23–42, 1947 Powell, Marvin A., "Narām-Sîn, Son of Sargon: Ancient History, Famous Names, and a Famous Babylonian Forgery", Zeitschrift für Assyriologie und Vorderasiatische Archäologie, vol. 81, no. 1-2, pp.
The two substrates of this enzyme are L-DOPA and oxygen. Its initial product is 5-(L-alanin-3-yl)-2-hydroxy-cis,cis-muconate 6-semialdehyde. The intermediate readily cyclises and further oxidises, forming a 2-pyrone ring; this is stizolobinic acid, which is the product that is isolated and after which this enzyme is named.
That study was criticized as methodologically flawed, and had presented no evidence of a causal relation between the presence of a prosthetic breast and the occurrence of systemic disease. Upon investigation, the FDA concluded that the epidemiological evidence in the medical literature does not support an association between fibromyalgia and breast implants. Likewise, the review study, Silicone Breast implants and Connective tissue Disease: No Association (2011) reported that the scientific literature does not support any claims about a causal relation between prosthetic breasts and connective-tissue disease.
Docetaxel is used in the treatment of various cancers, including breast, lung, prostate, gastric, head and neck, and ovarian cancer. Clinical data have shown docetaxel to have cytotoxic activity against breast, colorectal, lung, ovarian, prostate, liver, renal, gastric, and head and neck cancers and melanoma. In hormone-refractory prostate cancer docetaxel improves life expectancy and overall life quality. The optimal dose scheduling of taxanes remains unconfirmed, but most studies find significant mortality benefit following either a three-week or a one-week administration schedule. While a 2010 article in Current Clinical Pharmacology states, "weekly administration has emerged as the optimal schedule," the official docetaxel package insert recommends administration every three weeks.
Sources: en.wikipedia.org
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.
The solid is usually kept desiccated at -20 °C or lower and protected from light. Stock solutions are aliquoted to limit freeze–thaw cycles. Aqueous solutions are not generally recommended for long-term storage.
Laws differ by country and by intended use. It is not an approved medicine, and many vendors sell it as a research chemical. Purchasers are responsible for confirming local restrictions.
It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.